Clinical Trial Update: Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-esophageal Reflux Disease (GERD) Patients With Night-time Heartburn Symptoms. [Phase 3]

View source ↗

Summary

An open-label Phase 3 study evaluated different dosing regimens of rabeprazole in GERD patients with night-time heartburn; the trial status indicates completion…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Heartburn

Drugs mentioned

• Rabeprazole (rabeprazole)

Snippet

Sponsor: Janssen-Ortho Inc., Canada | Conditions: Gastroesophageal Reflux, Heartburn | Phase 3 | Status: COMPLETED